Moderna is trading at $217.37, up 10.34%, with its Nasdaq-100 inclusion the clearest company-specific catalyst. - The inclusion took effect before the market opened on October 9, replacing Warner Bros. Discovery; index-tracking funds may have to buy shares to match the index. - Biotech shares have a supportive backdrop, with XBI up 2.50%; the broader market is also higher.